Henning Gruell

34PUBLICATIONS
190CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthMedical biotechnology not elsewhere classifiedPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 17, 2026
Association between CAR T-cell persistence and improved response to salvage radiotherapy in patients with DLBCL.

|Sep 15, 2026
Post-Exposure Prophylaxis with a monoclonal antibody cocktail Following Bundibugyo Ebolavirus Exposure in Adults and Children.

|Sep 15, 2026
A case of Bundibugyo virus disease treated with monoclonal antibodies and remdesivir.

|Jul 23, 2026
Investigation of Vaccine-Induced Immune Response After Vaccination Against Respiratory Viruses in Immunocompromised Patients With or Without Hemato-Oncological Diseases (RESPONSE): Protocol for a Prospective Cohort Study.

|Mar 03, 2026
Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.

Katie Fisher, Mauro A Garcia, Giacomo S Frattari

|Feb 03, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope.

Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde

Pageof 6

Frequent Collaborators

19 joint publications

Florian Klein

11 joint publications

Christoph Kreer

7 joint publications

Philipp Schommers

5 joint publications

Jesse D Bloom